CN104548048A - Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases - Google Patents
Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases Download PDFInfo
- Publication number
- CN104548048A CN104548048A CN201510044938.8A CN201510044938A CN104548048A CN 104548048 A CN104548048 A CN 104548048A CN 201510044938 A CN201510044938 A CN 201510044938A CN 104548048 A CN104548048 A CN 104548048A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- fructus
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 208000020084 Bone disease Diseases 0.000 title abstract 2
- 208000025747 Rheumatic disease Diseases 0.000 title abstract 2
- 208000000491 Tendinopathy Diseases 0.000 title abstract 2
- 208000023835 Tendon disease Diseases 0.000 title abstract 2
- 230000000552 rheumatic effect Effects 0.000 title abstract 2
- 210000002435 tendon Anatomy 0.000 title abstract 2
- 241000218176 Corydalis Species 0.000 claims abstract description 17
- 244000046101 Sophora japonica Species 0.000 claims abstract description 11
- 235000010586 Sophora japonica Nutrition 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 15
- 239000002674 ointment Substances 0.000 claims description 14
- 208000012659 Joint disease Diseases 0.000 claims description 13
- 208000029578 Muscle disease Diseases 0.000 claims description 13
- 210000003205 muscle Anatomy 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 239000009670 cang er zi wan Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000008589 Cortex Fraxini Substances 0.000 claims description 5
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 5
- 240000002448 Ipomoea quamoclit Species 0.000 claims description 5
- 241001646826 Isodon rubescens Species 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 5
- 235000011613 Pinus brutia Nutrition 0.000 claims description 5
- 241000018646 Pinus brutia Species 0.000 claims description 5
- 241000081623 Sabia parviflora Species 0.000 claims description 5
- 241000203383 Schefflera Species 0.000 claims description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000007919 dispersible tablet Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract 4
- 241000227129 Aconitum Species 0.000 abstract 1
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 240000000425 Chaenomeles speciosa Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000001980 Cucurbita pepo Species 0.000 abstract 1
- 235000009852 Cucurbita pepo Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000302544 Luffa aegyptiaca Species 0.000 abstract 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 11
- 208000006820 Arthralgia Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000005224 forefinger Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating rheumatic tendon and bone diseases. The traditional Chinese medicine composition comprises the following substances in parts by weight: 3-6 parts of common monkshood mother root, 3-6 parts of kusnezoff monkshood root, 3-6 parts of safflower, 3-6 parts of Chinese angelica, 3-10 parts of cassia twigs, 3-9 parts of Szechuan lovage rhizome, 3-6 parts of common clubmoss herb, 6-10 parts of herba erodii, 3-9 parts of caulis polygoni multiflori, 3-6 parts of rhizoma corydalis, 3-6 parts of Chinese thorowax root, 3-6 parts of peach seeds, 6-10 parts of mulberry leaves, 6-10 parts of sophora japonica leaves, 10-20 parts of barbary wolfberry fruits, 3-6 parts of kudzuvine root, 3-8 parts of siberian cocklour fruits, 3-6 parts of divaricate saposhnikovia root, 6-10 parts of glossy privet fruits, 3-6 parts of common floweringquince fruits, 12-20 parts of towel gourd vegetable sponge, 3-10 parts of ephedra herb, 3-9 parts of incised notopterygium rhizome, 3-6 parts of liquorice root and 3-6g of dried ginger. The traditional Chinese medicine composition provided by the invention has the advantages of mutual influence, synergy and significant curative effect, and is very worthy of great popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition of nursing for treating rheumatism muscle and joint disease.
Background technology
Rheumatism is a kind of with swelling, arthralgia and the disease being deformed into main manifestations, Etiological is for caused by various factors invades in people to joint and surrounding tissue thereof, strong stiff sense, pain, heating sense etc. is felt in the many meetings of patient, it is tingle etc. that the lighter there will be erythema, extremity, the vital tissue organ of severe one to patient causes damage, even threat to life two rheumatism belongs to " arthromyodynia " category, the pathogenesis causing this disease is very complicated, wet, wind, poison and the factor such as hot all can cause, and the sickness rate of rheumatism muscle and joint disease presents the trend of rising.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of rheumatism muscle and joint disease.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of rheumatism muscle and joint disease, it comprises the material of following weight portion: Radix Aconiti 3-6 part, Radix Aconiti Kusnezoffii 3-6 part, Flos Carthami 3-6 part, Radix Angelicae Sinensis 3-6 part, Ramulus Cinnamomi 3-10 part, Rhizoma Chuanxiong 3-9 part, Herba Lycopodii 3-6 part, Herba Erodii 6-10 part, Caulis Polygoni Multiflori 3-9 part, Rhizoma Corydalis 3-6 part, Radix Bupleuri 3-6 part, Semen Persicae 3-6 part, Folium Mori 6-10 part, Japanese pagodatree leaf 6-10 part, Fructus Lycii 10-20 part, Radix Puerariae 3-6 part, Fructus Xanthii 3-8 part, Radix Saposhnikoviae 3-6 part, Fructus Ligustri Lucidi 6-10 part, Fructus Chaenomelis 3-6 part, Retinervus Luffae Fructus 12-20 part, Herba Ephedrae 3-10 part, Rhizoma Et Radix Notopterygii 3-9 part, Radix Glycyrrhizae 3-6 part and Rhizoma Zingiberis 3-6 gram.
Preferably, the Chinese medicine composition for the treatment of rheumatism muscle and joint disease of the present invention comprises the material of following weight portion: Radix Aconiti 3 parts, Radix Aconiti Kusnezoffii 3 parts, 5 parts, Flos Carthami, Radix Angelicae Sinensis 5 parts, Ramulus Cinnamomi 8 parts, Rhizoma Chuanxiong 8 parts, Herba Lycopodii 5 parts, Herba Erodii 7 parts, Caulis Polygoni Multiflori 5 parts, Rhizoma Corydalis 3 parts, Radix Bupleuri 5 parts, 5 parts, Semen Persicae, 8 parts, Folium Mori, Japanese pagodatree leaf 8 parts, Fructus Lycii 15 parts, Radix Puerariae 5 parts, Fructus Xanthii 7 parts, Radix Saposhnikoviae 5 parts, Fructus Ligustri Lucidi 8 parts, Fructus Chaenomelis 5 parts, Retinervus Luffae Fructus 15 parts, 8 parts, Herba Ephedrae, Rhizoma Et Radix Notopterygii 5 parts, 5 parts, Radix Glycyrrhizae and Rhizoma Zingiberis 5 grams.
Preferably, the Chinese medicine composition for the treatment of rheumatism muscle and joint disease of the present invention also comprises the material of following weight portion: Herba Corydalis tailensis 5 parts, Herba Epimedii 3 parts, Herba Stachytarphetae Jamaicensis 3 parts, Herba Patriniae 5 parts, Indigo Naturalis 5 parts, spend schefflera 5 parts, Semen Cassiae 6 parts, Rabdosia rubescens 3 parts, Herba Begoniae Laciniatae 3 parts, cypress vine pine 2 parts, Fructus Aurantii (parched) 3 parts, Fructus Ligustri Lucidi 5 parts, Herba Clerodendri fortunati 3 parts, rust hair Cortex Fraxini Malacophyllae Radicis 5 parts, Flos Chimonanthi Praecocis 3 parts and Sabia parviflora Wall.ex Roxb 3 parts in vain.
Preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, soft capsule or ointment.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment rheumatism muscle and joint disease, described compositions comprises the material of following weight portion: Radix Aconiti 3-6 part, Radix Aconiti Kusnezoffii 3-6 part, Flos Carthami 3-6 part, Radix Angelicae Sinensis 3-6 part, Ramulus Cinnamomi 3-10 part, Rhizoma Chuanxiong 3-9 part, Herba Lycopodii 3-6 part, Herba Erodii 6-10 part, Caulis Polygoni Multiflori 3-9 part, Rhizoma Corydalis 3-6 part, Radix Bupleuri 3-6 part, Semen Persicae 3-6 part, Folium Mori 6-10 part, Japanese pagodatree leaf 6-10 part, Fructus Lycii 10-20 part, Radix Puerariae 3-6 part, Fructus Xanthii 3-8 part, Radix Saposhnikoviae 3-6 part, Fructus Ligustri Lucidi 6-10 part, Fructus Chaenomelis 3-6 part, Retinervus Luffae Fructus 12-20 part, Herba Ephedrae 3-10 part, Rhizoma Et Radix Notopterygii 3-9 part, Radix Glycyrrhizae 3-6 part and Rhizoma Zingiberis 3-6 gram.
Preferably, described compositions comprises the material of following weight portion: Radix Aconiti 3 parts, Radix Aconiti Kusnezoffii 3 parts, 5 parts, Flos Carthami, Radix Angelicae Sinensis 5 parts, Ramulus Cinnamomi 8 parts, Rhizoma Chuanxiong 8 parts, Herba Lycopodii 5 parts, Herba Erodii 7 parts, Caulis Polygoni Multiflori 5 parts, Rhizoma Corydalis 3 parts, Radix Bupleuri 5 parts, 5 parts, Semen Persicae, 8 parts, Folium Mori, Japanese pagodatree leaf 8 parts, Fructus Lycii 15 parts, Radix Puerariae 5 parts, Fructus Xanthii 7 parts, Radix Saposhnikoviae 5 parts, Fructus Ligustri Lucidi 8 parts, Fructus Chaenomelis 5 parts, Retinervus Luffae Fructus 15 parts, 8 parts, Herba Ephedrae, Rhizoma Et Radix Notopterygii 5 parts, 5 parts, Radix Glycyrrhizae and Rhizoma Zingiberis 5 grams.
Preferably, described compositions also comprises the material of following weight portion: Herba Corydalis tailensis 5 parts, Herba Epimedii 3 parts, Herba Stachytarphetae Jamaicensis 3 parts, Herba Patriniae 5 parts, Indigo Naturalis 5 parts, spend schefflera 5 parts, Semen Cassiae 6 parts, Rabdosia rubescens 3 parts, Herba Begoniae Laciniatae 3 parts, cypress vine pine 2 parts, Fructus Aurantii (parched) 3 parts, Fructus Ligustri Lucidi 5 parts, Herba Clerodendri fortunati 3 parts, rust hair Cortex Fraxini Malacophyllae Radicis 5 parts, Flos Chimonanthi Praecocis 3 parts and Sabia parviflora Wall.ex Roxb 3 parts in vain.
Preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, soft capsule or ointment.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 ointment of the present invention
Take Radix Aconiti 3 grams, Radix Aconiti Kusnezoffii 3 grams, 5 grams, Flos Carthami, Radix Angelicae Sinensis 5 grams, Ramulus Cinnamomi 8 grams, Rhizoma Chuanxiong 8 grams, Herba Lycopodii 5 grams, Herba Erodii 7 grams, Caulis Polygoni Multiflori 5 grams, Rhizoma Corydalis 3 grams, Radix Bupleuri 5 grams, 5 grams, Semen Persicae, 8 grams, Folium Mori, Japanese pagodatree leaf 8 grams, Fructus Lycii 15 grams, Radix Puerariae 5 grams, Fructus Xanthii 7 grams, Radix Saposhnikoviae 5 grams, Fructus Ligustri Lucidi 8 grams, Fructus Chaenomelis 5 grams, Retinervus Luffae Fructus 15 grams, 8 grams, Herba Ephedrae, Rhizoma Et Radix Notopterygii 5 grams, 5 grams, Radix Glycyrrhizae and Rhizoma Zingiberis 5 grams, pulverize, cross 30 mesh sieves, add dehydrated alcohol 2000 milliliters, heating 2 hours under the condition of backflow, be cooled to room temperature, adding water to alcohol content is 65 volume %, at room temperature, hold over night, filter, make filtrate evaporate to dryness, pulverize, add lanoline 300 grams, mix homogeneously, obtain.
Embodiment 2 ointment of the present invention
Take Radix Aconiti 3 grams, Radix Aconiti Kusnezoffii 3 grams, 5 grams, Flos Carthami, Radix Angelicae Sinensis 5 grams, Ramulus Cinnamomi 8 grams, Rhizoma Chuanxiong 8 grams, Herba Lycopodii 5 grams, Herba Erodii 7 grams, Caulis Polygoni Multiflori 5 grams, Rhizoma Corydalis 3 grams, Radix Bupleuri 5 grams, 5 grams, Semen Persicae, 8 grams, Folium Mori, Japanese pagodatree leaf 8 grams, Fructus Lycii 15 grams, Radix Puerariae 5 grams, Fructus Xanthii 7 grams, Radix Saposhnikoviae 5 grams, Fructus Ligustri Lucidi 8 grams, Fructus Chaenomelis 5 grams, Retinervus Luffae Fructus 15 grams, 8 grams, Herba Ephedrae, Rhizoma Et Radix Notopterygii 5 grams, 5 grams, Radix Glycyrrhizae, Rhizoma Zingiberis 5 grams, Herba Corydalis tailensis 5 grams, Herba Epimedii 3 grams, Herba Stachytarphetae Jamaicensis 3 grams, Herba Patriniae 5 grams, Indigo Naturalis 5 grams, spend schefflera 5 grams in vain, Semen Cassiae 6 grams, Rabdosia rubescens 3 grams, Herba Begoniae Laciniatae 3 grams, cypress vine pine 2 grams, Fructus Aurantii (parched) 3 grams, Fructus Ligustri Lucidi 5 grams, Herba Clerodendri fortunati 3 grams, rust hair Cortex Fraxini Malacophyllae Radicis 5 grams, Flos Chimonanthi Praecocis 3 grams and Sabia parviflora Wall.ex Roxb 3 grams, pulverize, and crosses 30 mesh sieves, add dehydrated alcohol 2000 milliliters, under the condition of backflow, heating 2 hours, is cooled to room temperature, adding water to alcohol content is 65 volume %, at room temperature, and hold over night, filter, make filtrate evaporate to dryness, pulverize, add lanoline 300 grams, mix homogeneously, to obtain final product.
Experimental example
Diagnostic criteria
Reference " new Chinese medicine guideline of clinical investigations (trying) " (Zheng Xiao cornel. new Chinese medicine guideline of clinical investigations (trying) [M]. Beijing: China Medical Science Press, 2002:115-119.) draft.Damp-heat arthralgia resistance, syndrome of static blood blocking collaterals, primary symptom: arthralgia, swelling, the heating of touching or color of the leather rubescent, pain night, very morning was stiff, tenderness (tenderness), joint motion limited (joint stuffiness).Secondary disease: 1. generate heat, body temperature > 37.5 DEG C; 2. thirsty or thirst but no desire to drink; 3. antiperspirant goes out; 4. large dry stool; 5. yellow urine; 6. subcutaneous induration; 7. unhappy.Dimly red tongue, or have ecchymosis or addiction point, yellow fur, stringy and rolling pulse.There are 3 persons in primary symptom and time disease 7, in conjunction with tongue arteries and veins, diagnosable.
Selector close standard of stating patient 100 example, wherein man 60 example, female 40 example, 48.5 ± 5.5 years old mean age; Average course of disease is 30.6 ± 5.4 months.Be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 50 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the ointment of preparation in embodiment 1 to treat, every day twice, and each use 30 grams of ointment uniform application, at arthralgia position, are treated 30 days continuously.
Treatment group 2 uses the ointment of preparation in embodiment 2 to treat, every day twice, and each use 30 grams of ointment uniform application, at arthralgia position, are treated 30 days continuously.
Criterion of therapeutical effect
With reference to the efficacy assessment standard (Yang Cangliang of rheumatism Professional Committee of CAIM (Chinese Association Of Integrative Medicine) Kunming meeting revision, Wu Qifu. the 9th the national combination of Chinese and Western medicine rheumatism academic conference of rheumatism Professional Committee of CAIM (Chinese Association Of Integrative Medicine) is held [J] in Kunming. Chinese combination of Chinese and Western medicine magazine, 2012 (2): 78.) formulate.Cure: clinical symptom disappearance, can carry out various activity flexibly, anti-chain " O ", erythrocyte sedimentation rate and rheumatoid factor are all normal.Take a turn for the better: clinical symptoms is obviously alleviated, and activity is slightly limited, and anti-chain " O ", erythrocyte sedimentation rate and rheumatoid factor are not recovered completely.Invalid: clinical symptoms and analysis data unchanged.Worsen: clinical symptoms is not only effectively alleviated, but more serious.
Statistical method
Utilize SPSS 15.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts χ
2inspection, P < 0.05 represents that difference has statistical significance.
Result
Through treatment, for treatment group 1, cure 21 examples, take a turn for the better 22 examples, invalid 7 examples, and total effective rate is 86%, for treatment group 2, cures 34 examples, and take a turn for the better 15 examples, and invalid 1 example, total effective rate is 98%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).Observing over the course for the treatment of, all there is not obvious untoward reaction in two groups of patients.
Model case
Thank so-and-so, female, 49 years old, peasant, in the obvious inducement of Rhizoma Corydalis Decumbentis in 2014, patient occurred that right hand forefinger, left knee joint, left ankle joint swell and ache, joint stuffiness, and companion's deadlock in morning about 2 hours, through being diagnosed as rheumatoid arthritis.Use the ointment of preparation in embodiment 1 to treat, every day twice, use 30 grams of ointment uniform application at arthralgia position at every turn, continuously treatment 30 days.Clinical symptom disappearance, can carry out various activity flexibly, and anti-chain " O ", erythrocyte sedimentation rate and rheumatoid factor are all normal.Follow up a case by regular visits to and do not recur so far.
High certain, man, 52 years old.Have and occupy wetland history for a long time, symptom: grade fever symptom, the gonalgia is red and swollen, recurrent exerbation.Be diagnosed as rheumatoid arthritis.Use the ointment of preparation in embodiment 2 to treat, every day twice, use 30 grams of ointment uniform application at arthralgia position at every turn, continuously treatment 30 days.Clinical symptom disappearance, can carry out various activity flexibly, and anti-chain " O ", erythrocyte sedimentation rate and rheumatoid factor are all normal.Follow up a case by regular visits to and do not recur so far.
Claims (8)
1. treat the Chinese medicine composition of rheumatism muscle and joint disease for one kind, it is characterized in that, it comprises the material of following weight portion: Radix Aconiti 3-6 part, Radix Aconiti Kusnezoffii 3-6 part, Flos Carthami 3-6 part, Radix Angelicae Sinensis 3-6 part, Ramulus Cinnamomi 3-10 part, Rhizoma Chuanxiong 3-9 part, Herba Lycopodii 3-6 part, Herba Erodii 6-10 part, Caulis Polygoni Multiflori 3-9 part, Rhizoma Corydalis 3-6 part, Radix Bupleuri 3-6 part, Semen Persicae 3-6 part, Folium Mori 6-10 part, Japanese pagodatree leaf 6-10 part, Fructus Lycii 10-20 part, Radix Puerariae 3-6 part, Fructus Xanthii 3-8 part, Radix Saposhnikoviae 3-6 part, Fructus Ligustri Lucidi 6-10 part, Fructus Chaenomelis 3-6 part, Retinervus Luffae Fructus 12-20 part, Herba Ephedrae 3-10 part, Rhizoma Et Radix Notopterygii 3-9 part, Radix Glycyrrhizae 3-6 part and Rhizoma Zingiberis 3-6 gram.
2. the Chinese medicine composition for the treatment of rheumatism muscle and joint disease according to claim 1, it is characterized in that, it comprises the material of following weight portion: Radix Aconiti 3 parts, Radix Aconiti Kusnezoffii 3 parts, 5 parts, Flos Carthami, Radix Angelicae Sinensis 5 parts, Ramulus Cinnamomi 8 parts, Rhizoma Chuanxiong 8 parts, Herba Lycopodii 5 parts, Herba Erodii 7 parts, Caulis Polygoni Multiflori 5 parts, Rhizoma Corydalis 3 parts, Radix Bupleuri 5 parts, 5 parts, Semen Persicae, 8 parts, Folium Mori, Japanese pagodatree leaf 8 parts, Fructus Lycii 15 parts, Radix Puerariae 5 parts, Fructus Xanthii 7 parts, Radix Saposhnikoviae 5 parts, Fructus Ligustri Lucidi 8 parts, Fructus Chaenomelis 5 parts, Retinervus Luffae Fructus 15 parts, 8 parts, Herba Ephedrae, Rhizoma Et Radix Notopterygii 5 parts, 5 parts, Radix Glycyrrhizae and Rhizoma Zingiberis 5 grams.
3. the Chinese medicine composition for the treatment of rheumatism muscle and joint disease according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Herba Corydalis tailensis 5 parts, Herba Epimedii 3 parts, Herba Stachytarphetae Jamaicensis 3 parts, Herba Patriniae 5 parts, Indigo Naturalis 5 parts, spend schefflera 5 parts, Semen Cassiae 6 parts, Rabdosia rubescens 3 parts, Herba Begoniae Laciniatae 3 parts, cypress vine pine 2 parts, Fructus Aurantii (parched) 3 parts, Fructus Ligustri Lucidi 5 parts, Herba Clerodendri fortunati 3 parts, rust hair Cortex Fraxini Malacophyllae Radicis 5 parts, Flos Chimonanthi Praecocis 3 parts and Sabia parviflora Wall.ex Roxb 3 parts in vain.
4. the Chinese medicine composition for the treatment of rheumatism muscle and joint disease according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, soft capsule or ointment.
5. the purposes of compositions in the Chinese medicine of preparation treatment rheumatism muscle and joint disease, it is characterized in that, described compositions comprises the material of following weight portion: Radix Aconiti 3-6 part, Radix Aconiti Kusnezoffii 3-6 part, Flos Carthami 3-6 part, Radix Angelicae Sinensis 3-6 part, Ramulus Cinnamomi 3-10 part, Rhizoma Chuanxiong 3-9 part, Herba Lycopodii 3-6 part, Herba Erodii 6-10 part, Caulis Polygoni Multiflori 3-9 part, Rhizoma Corydalis 3-6 part, Radix Bupleuri 3-6 part, Semen Persicae 3-6 part, Folium Mori 6-10 part, Japanese pagodatree leaf 6-10 part, Fructus Lycii 10-20 part, Radix Puerariae 3-6 part, Fructus Xanthii 3-8 part, Radix Saposhnikoviae 3-6 part, Fructus Ligustri Lucidi 6-10 part, Fructus Chaenomelis 3-6 part, Retinervus Luffae Fructus 12-20 part, Herba Ephedrae 3-10 part, Rhizoma Et Radix Notopterygii 3-9 part, Radix Glycyrrhizae 3-6 part and Rhizoma Zingiberis 3-6 gram.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Radix Aconiti 3 parts, Radix Aconiti Kusnezoffii 3 parts, 5 parts, Flos Carthami, Radix Angelicae Sinensis 5 parts, Ramulus Cinnamomi 8 parts, Rhizoma Chuanxiong 8 parts, Herba Lycopodii 5 parts, Herba Erodii 7 parts, Caulis Polygoni Multiflori 5 parts, Rhizoma Corydalis 3 parts, Radix Bupleuri 5 parts, 5 parts, Semen Persicae, 8 parts, Folium Mori, Japanese pagodatree leaf 8 parts, Fructus Lycii 15 parts, Radix Puerariae 5 parts, Fructus Xanthii 7 parts, Radix Saposhnikoviae 5 parts, Fructus Ligustri Lucidi 8 parts, Fructus Chaenomelis 5 parts, Retinervus Luffae Fructus 15 parts, 8 parts, Herba Ephedrae, Rhizoma Et Radix Notopterygii 5 parts, 5 parts, Radix Glycyrrhizae and Rhizoma Zingiberis 5 grams.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Herba Corydalis tailensis 5 parts, Herba Epimedii 3 parts, Herba Stachytarphetae Jamaicensis 3 parts, Herba Patriniae 5 parts, Indigo Naturalis 5 parts, spend schefflera 5 parts, Semen Cassiae 6 parts, Rabdosia rubescens 3 parts, Herba Begoniae Laciniatae 3 parts, cypress vine pine 2 parts, Fructus Aurantii (parched) 3 parts, Fructus Ligustri Lucidi 5 parts, Herba Clerodendri fortunati 3 parts, rust hair Cortex Fraxini Malacophyllae Radicis 5 parts, Flos Chimonanthi Praecocis 3 parts and Sabia parviflora Wall.ex Roxb 3 parts in vain.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, soft capsule or ointment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510044938.8A CN104548048A (en) | 2015-01-29 | 2015-01-29 | Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510044938.8A CN104548048A (en) | 2015-01-29 | 2015-01-29 | Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104548048A true CN104548048A (en) | 2015-04-29 |
Family
ID=53065819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510044938.8A Pending CN104548048A (en) | 2015-01-29 | 2015-01-29 | Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104548048A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213929A (en) * | 2015-09-21 | 2016-01-06 | 董春年 | A kind of Chinese medicine for the treatment of rheumatism and preparation method thereof |
| CN110721293A (en) * | 2018-07-17 | 2020-01-24 | 马成英 | Traditional Chinese medicine composition for treating rheumatic muscle and bone diseases |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1102783A (en) * | 1994-04-18 | 1995-05-24 | 张振声 | Rheumatism-curing infused medicine and its preparation |
| CN101703626A (en) * | 2009-11-27 | 2010-05-12 | 阚恭勇 | Medicament for treating rheumatoid arthritis |
| JP2011111405A (en) * | 2009-11-25 | 2011-06-09 | Univ Of Yamanashi | Glial cell-activation inhibition composition |
| CN103211932A (en) * | 2013-03-18 | 2013-07-24 | 赵霞 | Traditional Chinese medicine composition for treating rheumatism |
-
2015
- 2015-01-29 CN CN201510044938.8A patent/CN104548048A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1102783A (en) * | 1994-04-18 | 1995-05-24 | 张振声 | Rheumatism-curing infused medicine and its preparation |
| JP2011111405A (en) * | 2009-11-25 | 2011-06-09 | Univ Of Yamanashi | Glial cell-activation inhibition composition |
| CN101703626A (en) * | 2009-11-27 | 2010-05-12 | 阚恭勇 | Medicament for treating rheumatoid arthritis |
| CN103211932A (en) * | 2013-03-18 | 2013-07-24 | 赵霞 | Traditional Chinese medicine composition for treating rheumatism |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213929A (en) * | 2015-09-21 | 2016-01-06 | 董春年 | A kind of Chinese medicine for the treatment of rheumatism and preparation method thereof |
| CN110721293A (en) * | 2018-07-17 | 2020-01-24 | 马成英 | Traditional Chinese medicine composition for treating rheumatic muscle and bone diseases |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
| CN104173951A (en) | Traditional Chinese medicine composition for nursing and treating gastroduodenal ulcer | |
| CN104548048A (en) | Traditional Chinese medicine composition for treating rheumatic tendon and bone diseases | |
| CN103341153B (en) | Traditional Chinese medicine composition for treating raynaud disease | |
| CN102225118B (en) | Blood-activating wind-dispelling liquid | |
| CN104587398A (en) | Microorganism fermented traditional Chinese medicinal preparation as well as preparation method and application thereof | |
| CN104758440A (en) | Traditional Chinese medicine for treating ischialgia | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN104189847A (en) | Traditional Chinese medicine for treating tuberculous exadative pleurisy | |
| CN103550334A (en) | Traditional Chinese medicine composition for treating diabetic peripheral neuropathy and application thereof | |
| CN103405635A (en) | Traditional Chinese medicine composition for treating middle and old aged constipation | |
| CN105770748A (en) | Traditional Chinese medicine composition for treating gouts | |
| CN104491832A (en) | Traditional Chinese medicine composition used for treating osteoproliferation | |
| CN104127787A (en) | Traditional Chinese medicinal plaster for treating constipations | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN104815198A (en) | Traditional Chinese medicinal decoction for treating diabetes | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN109939212A (en) | A kind of traditional Chinese medicine preparation for treating axillary nerve injury and preparation method | |
| CN105106847B (en) | One treats menorrheal pharmaceutical composition and application thereof | |
| CN103463560A (en) | Traditional Chinese medicine composition for treating rosacea | |
| CN104547246A (en) | Traditional Chinese medicine composition for treating haemorrhoids | |
| CN105148161A (en) | Traditional Chinese medicine preparation for treating infantile suppurative tonsillitis | |
| CN104547138A (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN105147971A (en) | Traditional Chinese medicine preparation for treating infantile suppurative tonsillitis | |
| CN104491645A (en) | External use plaster used for treating bone diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |